Related Experiment Video
Updated: Jun 19, 2026
08:26
Luminophore Formation in Various Conformations of Bovine Serum Albumin by Binding of Gold(III)
Published on: August 31, 2018
[Study on the interaction between daidzein and human serum albumin]
Qiu-Hua Wu1, Dong-Yue Wang, Xin Zhou
1College of Science, Agricultural University of Hebei, Baoding 071001, China. wqh69@yahoo.com.cn
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu
|October 6, 2009
Summary
Daidzein binding to human serum albumin (HSA) causes fluorescence quenching, primarily through static mechanisms. Hydrophobic interactions are key drivers of this interaction, influencing HSA conformation.
Area of Science:
- Biochemistry
- Molecular Biology
- Spectroscopy
Context:
- Human serum albumin (HSA) is a crucial protein involved in drug transport and metabolism.
- Daidzein, a soy isoflavone, possesses potential therapeutic properties.
- Understanding the interaction between daidzein and HSA is vital for its pharmacokinetic and pharmacodynamic profiling.
Purpose:
- To investigate the binding mechanism and thermodynamics between daidzein and human serum albumin (HSA).
- To elucidate the effect of daidzein on the conformational changes of HSA.
Summary:
- Fluorescence quenching, synchronous fluorescence, and ultraviolet spectra revealed that daidzein quenches HSA's intrinsic fluorescence.
- The primary quenching mechanism is static, involving non-radiative energy transfer within a single molecule.
- Binding constants and distances were determined at different temperatures, indicating temperature-dependent binding.
- Thermodynamic analysis suggests hydrophobic forces are dominant in the daidzein-HSA interaction.
- Synchronous spectra demonstrated daidzein alters HSA's conformation.
Impact:
- Provides insights into the molecular interactions between a dietary compound and a key human protein.
- Contributes to understanding the disposition and potential efficacy of daidzein in biological systems.
- Highlights the role of hydrophobic forces and conformational changes in protein-ligand binding.
Related Concept Videos
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
01:29Drug Distribution: Plasma Protein Binding
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
01:30Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
01:23Factors Affecting Protein-Drug Binding: Drug Interactions
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...